Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.
<h4>Background</h4>New agents with neuroprotective or neuroregenerative potential might be explored in primary-progressive Multiple Sclerosis (PPMS)--the MS disease course with leading neurodegenerative pathology. Identification of patients with a high short-term risk for progression may...
Guardado en:
Autores principales: | Jan-Patrick Stellmann, Anneke Neuhaus, Christian Lederer, Martin Daumer, Christoph Heesen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18251039226e4f86b3d219c7fbe9fd0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
T1 Relaxation Times in the Cortex and Thalamus Are Associated With Working Memory and Information Processing Speed in Patients With Multiple Sclerosis
por: Christian Thaler, et al.
Publicado: (2021) -
Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study
por: Hamdy SM, et al.
Publicado: (2017) -
Graves’ disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis
por: Duarte Diana Borges, et al.
Publicado: (2021) -
Brain viscoelasticity alteration in chronic-progressive multiple sclerosis.
por: Kaspar-Josche Streitberger, et al.
Publicado: (2012) -
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
por: Afsaneh Shirani, et al.
Publicado: (2010)